GluR2 receptor modulators
OwnerJames Eric Gouaux, Langzhou Song +2inventors
InventorsJames Eric Gouaux, Langzhou Song, Yuli Xie, Donald W. Landry
Life of this patent
Estimating the term…
Abstract
The present invention provides for compositions and methods for modulating the GluR2 receptor. It is based, at least in part, on the discovery, by X-ray crystallography, that a known GluR2 agonist binds to the receptor in two different orientations, thereby diminishing its potency. The present invention provides for structural alternatives in which alternative binding possibilities are substantially eliminated.
Claims32
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound or a pharmaceutically acceptable salt thereof having the structure of formula 1:
- R1—R2R3R4—R5
- where R1 and R5 are the same and may be alkylaminosulfonyl, alkylaminosulfonylalkyl, alkylsulfonyl, alkylsulfonylalkyl, alkylaminocarbonyl, alkylaminocarbonylalkyl, alkylaminocarboxy, alkylaminocarboxyalkyl;
- where R2 and R4 are preferably, but not necessarily, the same, and are ring structures, optionally substituted, which may be aryl, cycloalkyl, or heterocyclyl;
- and
- where R3 may be a bond between R2 and R4 which either is shared by or joins the two rings without being shared in the rings themselves.
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound or a pharmaceutically acceptable salt thereof having the structure of formula 2:
- where R6 and R7 are the same or different and may be alkylaminosulfonyl, alkylaminosulfonylalkyl, alkylsulfonyl, alkylsulfonylalkyl, alkylaminocarbonyl, alkylaminocarbonylalkyl, alkylaminocarboxy, alkylaminocarboxyalkyl.
A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound or a pharmaceutically acceptable salt thereof having the structure of formula 4:
- where R8 and R9 are the same and may be alkylaminosulfonyl, alkylaminosulfonylalkyl, alkylsulfonyl, alkylsulfonylalkyl, alkylaminocarbonyl, alkylaminocarbonylalkyl, alkylaminocarboxy, alkylaminocarboxyalkyl.
The compound N,N′-(2R,2′R)-2,2′-(biphenyl-4,4′-diyl)bis(propane-2,1-diyl)dipropane-2-sulfonamide) or a pharmaceutically acceptable salt thereof.
The compound N,N′-(2S,2′S)-2,2′-(biphenyl-4,4′-diyl)bis(2-fluoropropane-2,1-diyl)dipropane-2-sulfonamide) or a pharmaceutically acceptable salt thereof.
The compound N,N′-(2S,2′S)-2,2′-(biphenyl-4,4′-diyl)bis(2-hydroxypropane-2,1-diyl)dipropane-2-sulfonamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.